Inside Sales

Background

A CCO with a large BD team across multiple therapeutic areas was facing limitations with his internal inside sales function. The legacy Inside Sales team was underdelivering, while cost pressure and need for BD productivity and leverage was creating a need for change.

Solution

Customized Outreach Campaigns

Conference Support

CDA Coordination

Regular Market Intelligence

Weekly funding & BD Updates

Quarterly Market Analysis Reports

Support to BD Across

CDA coordination

RFP discussions

Deal-closure enablement

Impact in First Six Months
of Engagement

25+ qualified meetings secured with relevant biotechnology and pharma companies.

3 active deal stage discussions initiated.

Client satisfaction led to expansion discussions and plans to add additional resources beyond the initial 1+1model to 3+1.

Delivered a measurable uplift in pipeline momentum while reducing operational costs.